You are here

Alternative splicing of VEGF

Description 
Alternative splicing is a regulatory pathway that can can change the messenger RNA produced from a gene and subsequently the proteins that are generated. If the message is changed by alternative splicing, this can change the kind of protein made, including its structure or function. Splicing means that even without changing your genes you can change their product. If harnessed this provides a method to turn off bad genes, turn on good genes or even switch the code to that a bad gene only makes good protein products. For example splicing can change the message "born with bad luck" into "born with luck" by skipping a coding sequence. The gene VEGF is partly regulated by splicing. This project aims to harness this splicing to develop a simple way to silence its 'bad' domain, to reduce abnormal blood vessel growth in the eye involved in progressive eye damage in diabetes.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
alternative splicing, retinopathy, RNA, oligonucleotide
School 
School of Translational Medicine » Diabetes
Available options 
PhD/Doctorate
Masters by research
BMedSc(Hons)
Joint PhD/Exchange Program
Time commitment 
Full-time
Top-up scholarship funding available 
No
Physical location 
The Alfred Centre 99 Commercial Road, Melbourne, Vic 3004
Co-supervisors 
Miss 
Raelene Pickering

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.